Drugs not developed because they are not as profitable as others, hospitals and pharmacies running out of life-saving medicines with no alternative, unexplained price hikes, etc. These are a few examples of the hurdles EU consumers face when trying to access the medicines they need.

We need an all-out effort to develop new treatments that meet our health needs, to make price tags become more reasonable, ethical and sustainable and to tackle anticompetitive moves.